Evidence map›Paper›PMID 29065776›Full record

ArticleTissue engineering. Part A2018

Phosphate Functional Groups Improve Oligo[(Polyethylene Glycol) Fumarate] Osteoconduction and BMP-2 Osteoinductive Efficacy.

Maurits G L Olthof, Marianna A Tryfonidou, Xifeng Liu, Behdad Pouran, Björn P Meij, Wouter J A Dhert, Michael J Yaszemski, Lichun Lu, Jacqueline Alblas, Diederik H R Kempen

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. SDF-1Stem cells international · 2021
    Article
  8. Article
  9. BMP and TGFβ use and release in bone regenerationTurkish journal of medical sciences · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Maurits G L Olthof1 Department of Orthopedics, University Medical Center , Utrecht, The Netherlands .
Marianna A Tryfonidou4 Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University , Utrecht, The Netherlands .
Xifeng Liu2 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine , Rochester, Minnesota.
Behdad Pouran1 Department of Orthopedics, University Medical Center , Utrecht, The Netherlands .
Björn P Meij4 Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University , Utrecht, The Netherlands .
Wouter J A Dhert1 Department of Orthopedics, University Medical Center , Utrecht, The Netherlands .
Michael J Yaszemski2 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine , Rochester, Minnesota.
Lichun Lu2 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine , Rochester, Minnesota.
Jacqueline Alblas1 Department of Orthopedics, University Medical Center , Utrecht, The Netherlands .
Diederik H R Kempen6 Department of Orthopaedic Surgery, Onze Lieve Vrouwe Gasthuis , Amsterdam, The Netherlands .
Utrecht University · NLMayo Clinic · USDelft University of Technology · NLOLVG · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Off-the-shelf availability in large quantities, drug delivery functionality, and modifiable chemistry and mechanical properties make synthetic polymers highly suitable candidates for bone grafting. However, most synthetic polymers lack the ability to support cell attachment, proliferation, migration, and differentiation, and ultimately tissue formation. Incorporating anionic peptides into the polymer that mimics acidic proteins, which contribute to biomineralization and cellular attachment, could enhance bone formation. Therefore, this study investigates the effect of a phosphate functional group on osteoconductivity and BMP-2-induced bone formation in an injectable and biodegradable oligo[(polyethylene glycol) fumarate] (OPF) hydrogel. Three types of OPF hydrogels were fabricated using 0%, 20%, or 40% Bis(2-(methacryloyloxy)ethyl) phosphate creating unmodified OPF-noBP and phosphate-modified OPF-BP20 and OPF-BP40, respectively. To account for the osteoinductive effect of various BMP-2 release profiles, two different release profiles (i.e., different ratios of burst and sustained release) were obtained by varying the BMP-2 loading method. To investigate the osteoconductive effect of phosphate modification, unloaded OPF composites were assessed for bone formation in a bone defect model after 3, 6, and 9 weeks. To determine the effect of the hydrogel phosphate modification on BMP-2-induced bone formation, BMP-2 loaded OPF composites with differential BMP-2 release were analyzed after 9 weeks of subcutaneous implantation in rats. The phosphate-modified OPF hydrogels (OPF-BP20 and OPF-BP40) generated significantly more bone in an orthotopic defect compared to the unmodified hydrogel (OPF-noBP). Furthermore, the phosphate functionalized surface-enhanced BMP-2-induced ectopic bone formation regardless of the BMP-2 release profile. In conclusion, this study clearly shows that phosphate functional groups improve the osteoconductive properties of OPF and enhanced BMP-2-induced bone formation. Therefore, functionalizing hydrogels with phosphate groups by crosslinking monomers into the hydrogel matrix could provide a valuable method for improving polymer characteristics and holds great promise for bone tissue engineering.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RegenerationMicroscopy, Electron, ScanningMicrospheresOsteogenesisPhosphatesPolyethylene GlycolsRatsBone Morphogenetic Protein 2PhosphatesPolyethylene Glycolsbone morphogenetic protein 2bone tissue engineeringoligo[(polyethylene glycol) fumarate]osteoconductionphosphate functional groups

Identifiers

PMID29065776
PMCPMC5963547
OpenAlexW2802410733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.